Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
Geopolitics threatens Chinese biotechs' hot out-licensing biz
For the first time, China biotechs out-licensed more assets in 2023 than they in-licensed.
Max Bayer
Apr 11, 2024 4:00am
BMS-backed TORL grabs $158M to march army of ADCs through clinic
Apr 10, 2024 9:35am
BMS' schizophrenia drug shows long-term benefit with new data
Apr 6, 2024 1:15pm
Bayer undergoes leadership shake-up—Chutes & Ladders
Mar 22, 2024 9:30am
Top 10 pharma R&D budgets in 2023
Mar 18, 2024 5:00am
Eli Lilly charts 2nd space trip with Redwire
Mar 12, 2024 9:44am